Share Price.com
Share Search

Shield Thera Share Price


Share Price: 114.50   Bid / Ask: 113.00 / 116.00   High: 116.00   Low: 109.08



Shield Thera is listed on the London Stock Exchange with ticker code STX, and is part of the Pharmaceuticals & Biotechnology sector. It has a market capitalisation of £134.07 m, with 117,088,657 shares in issue. Over the last year, Shield Thera has traded in a range of 89.00p, peaking at a high of 115.00p, with a low of 26.00p.


Shield Thera Share Price Value

Shield Thera Share Price
Shield Thera
Price114.50
Short CodeSTX
Change Today0.00
%ge Change4.57 %
Time17:30:00
High116.00
Low109.08
Open109.50
Yesterdays Close114.50
Volume Traded Today532,611
Shield Thera Share Price
Intra-day chart for Shield Thera
Shield Thera Intraday Chart
Shield Thera Intraday graph
Shield Thera Intraday Chart


Today’s Trade Volumes for Shield Thera

Recent Trades for STX

Recent Share Trades for Shield Thera (STX) (streaming)

Date
Time
Trade Prc
Volume
Value (approx)
21-May-19
14:50:19
111.35
100,000
111.35k
21-May-19
17:05:52
114.50
7,500
8,588
21-May-19
16:39:03
113.00
12,500
14.13k
21-May-19
16:26:43
115.00
141
162.15
21-May-19
16:09:10
114.00
4,385
4,999
21-May-19
16:09:00
112.03
858
961.22
21-May-19
16:08:25
111.08
18,550
20.61k
21-May-19
16:08:12
114.25
563
643.23
21-May-19
16:06:45
114.25
427
487.85


6 Month Graph for Shield Thera

Shield Thera 6 month graph

Share News for Shield Thera

HeadlineDate
Broker Forecast - finnCap issues a broker note on Shield Therapeutics Plc14 May '19
Shield Therapeutics iron deficiency treatment gets Swiss regulatory nod24 Apr '19
Director Deals - Shield Therapeutics Plc (STX)17 Apr '19
Broker Forecast - Peel Hunt issues a broker note on Shield Therapeutics Plc12 Mar '19
Shield Therapeutics records positive results from trial of iron deficiency treatment4 Mar '19
Broker Forecast - Liberum Capital issues a broker note on Shield Therapeutics Plc19 Feb '19
Shield Therapeutics reports promising results from iron-deficiency treatment study29 Jan '19
Shield Therapeutics appoints James Karis as chairman22 Jan '19
Shield Therapeutics partner starts selling iron deficiency treatment UK5 Dec '18
Shield Therapeutics iron deficiency treatment accepted by FDA for review3 Dec '18



Useful information about Shield Thera



Share Search
Share Search Share Search

Visit the Share Search.
Share Search

Share News
Share News



SharePrice.com will do their best to ensure the quality of the information displayed on this site, but all information is provided as-is, free of charge. We cannot be held responsible for any loss, material or otherwise, due to incorrect information found here. UK data supplied by NBTrader and Digital Look. Share Prices are at least 15 minutes delayed.